Methylcobalamin B12 is also indicated in those with pernicious anemia, diabetes, neuropathy, heart disease, circadian rhythm sleep disorders, memory loss, depression, fatigue, AIDS, inflammatory bowel disease (IBD), Lyme disease, osteoporosis, tendonitis, psychiatric disorders, Alzheimers disease, liver and kidney disease, and asthma
This is an introductory dose, not a therapeutic weight-loss dose
Cognitive symptoms, including memory problems and confusion, may show gradual improvement over three to six months, particularly in older adults
10.1134/s0006297914030146 99 IvanovB.AsadaK.KramerD
When healthcare innovators work together, we can make sure customer access moves at the same speed as innovation